Glide Pharmaceutical Technologies

Innovating patient compliance with solid dose therapeutics and vaccines for long-term health.

General Information
Company Name
Glide Pharmaceutical Technologies
Founded Year
2001
Location (Offices)
Founders / Decision Makers
Number of Employees
11-50
Industries
Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series Unknown
Social Media

Glide Pharmaceutical Technologies - Company Profile

Glide Pharmaceutical Technologies is a clinical-stage company specializing in solid dose formulations of therapeutics and vaccines. Their focus on developing the SDI, a solid dose injector system, aims to improve patient adherence to long-term self-administered treatments. The organization's pipeline includes solid dose formulations for octreotide, teriparatide, and vaccines for anthrax and influenza. Formerly known as Caretek Medical, Glide Pharmaceutical Technologies continues to innovate in the biotechnology, healthcare, and pharmaceutical industries.

Founded in 2001, the company received a £3.20M Venture Round investment on 01 February 2017. The investors in this round included Invesco, Oxford Technology Management, Oxford Capital, and HYGEA VCT PLC.

Taxonomy: pharmaceutical technology, clinical stage development, solid dose formulations, therapeutics, vaccines, self-administered treatments, patient compliance, long-term health, SDI injector system, octreotide, teriparatide, anthrax vaccine, influenza vaccine, patient adherence

Funding Rounds & Investors of Glide Pharmaceutical Technologies (5)

View All
Funding Stage Amount No. Investors Investors Date
Venture Round £3.20M 4
Invesco, investor in Glide Pharmaceutical Technologies's Venture Round round Oxford Technology Management, investor in Glide Pharmaceutical Technologies's Venture Round round Oxford Capital, investor in Glide Pharmaceutical Technologies's Venture Round round HYGEA VCT PLC, investor in Glide Pharmaceutical Technologies's Venture Round round
01 Feb 2017
Venture Round £14.00M 1
Invesco, investor in Glide Pharmaceutical Technologies's Venture Round round
27 Feb 2013
Series D $4.30M 2
Oxford Technology Management, investor in Glide Pharmaceutical Technologies's Series D round HYGEA VCT PLC, investor in Glide Pharmaceutical Technologies's Series D round
17 Mar 2010
Venture Round £2.30M 2
Oxford Technology Management, investor in Glide Pharmaceutical Technologies's Venture Round round Oxford Capital, investor in Glide Pharmaceutical Technologies's Venture Round round
13 Aug 2007
Venture Round £2.10M 1
Oxford Technology Management, investor in Glide Pharmaceutical Technologies's Venture Round round
07 Dec 2005

Latest News of Glide Pharmaceutical Technologies

View All

No recent news or press coverage available for Glide Pharmaceutical Technologies.

Similar Companies to Glide Pharmaceutical Technologies

View All
SpheroFill, LLC - Similar company to Glide Pharmaceutical Technologies
SpheroFill, LLC Next-generation drug delivery platform capable of protecting, delivering, and releasing API as solid, liquid, even gas.
Vaxess Technologies - Similar company to Glide Pharmaceutical Technologies
Vaxess Technologies Engineering Immunity for All
Stablepharma Limited - Similar company to Glide Pharmaceutical Technologies
Stablepharma Limited Stablepharma develops fridge-free, extended shelf-life versions of vaccines and pharmaceuticals to reduce waste and CO2.
MACLEODS PHARMACEUTICALS LTD. - Similar company to Glide Pharmaceutical Technologies
MACLEODS PHARMACEUTICALS LTD.
Molecular Formulations - Similar company to Glide Pharmaceutical Technologies
Molecular Formulations Delivering Precision in Pharmaceutical Sciences Through Innovative Drug Development
Circle Decoration Circle Decoration

Want to dive deeper into Glide Pharmaceutical Technologies? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now